	The role of exercise and lifestyle factors in fatigue among Parkinson's disease patients: a cross-sectional study. Neurol Sci Alshimemeri S, Shadid AM, Alsannat IA, Alamri NK, Almuslih RA. PMID: 41546733 [PubMed - in process]
	An attention-augmented multimodal classification of alzheimer's disease and parkinson's disease vs healthy controls using MRI, EEG, and SNP data. Sci Rep Shivahare BD, Rajadurai H, K D, Kansal S, Mathivanan SK, S K B S. PMID: 41545552 [PubMed - as supplied by publisher]
	Unraveling the intersection of aging and Parkinson's disease: a collaborative roadmap for advancing research models. NPJ Parkinsons Dis Schmidt MY, Cuervo AM, Double KL, Ehninger D, Goldberg MS, Harvey K, Hoeijmakers JHJ, Luk KC, Mastroberardino PG, Moore DJ, Niedernhofer LJ, Trudeau LÉ, Jurk D, Andersen JK, Bellantuono I. PMID: 41545406 [PubMed - as supplied by publisher]
	Visual misperceptions in favour of living beings in Parkinson's disease: A psychophysical study. Rev Neurol (Paris) Cleret de Langavant L, Mouton A, de Gardelle V, Kouider S, Bachoud-Lévi AC, Fénelon G, Remy P. PMID: 41545271 [PubMed - as supplied by publisher]
	Comparative Efficacy of 17 Rehabilitation Therapies Combined with Medication for Improving Gait Disorders and quality of life in Parkinson's Disease: A Network Meta-Analysis of 137 RCTs. Arch Phys Med Rehabil Lin X, Li H, Wu X. PMID: 41544924 [PubMed - as supplied by publisher]
	Clinical Study on Metabolic Differences in the Limbic System Between Non-Demented Parkinson's Disease Patients and Parkinson's Disease Dementia Patients. Behav Brain Res Wang Y, Shi X, Li L, Chen B, Xu L. PMID: 41544821 [PubMed - as supplied by publisher]
	Nanotechnology-Based Advancements in Parkinson's Therapy: Exploring Animal Models and Clinical Insights in Neurodegenerative Disorders. Ageing Res Rev Gadhave DG, Kale VV, Kade AP, Jadhav OR, Sugandhi VV, Babar VB, Khot S, Kokare CR, Paudel KR. PMID: 41544715 [PubMed - as supplied by publisher]
	Association between dairy consumption and Parkinson's disease: A systematic review and meta-analysis. Public Health Nepal G, Yang D, Ojha R, Tu Z. PMID: 41544344 [PubMed - as supplied by publisher]
	The road for developing new pharmacological therapies for Parkinson's disease: Current trends and targets in clinical trials. J Parkinsons Dis Machado T, Duarte GS, Outeiro TF, Ferreira JJ. PMID: 41543973 [PubMed - as supplied by publisher]
	Multi-omics Mendelian randomization and machine learning identify candidate therapeutic targets for Alzheimer's and Parkinson's diseases. Mamm Genome Li X, Zhang L, Xia J, Zheng M, Zhou Z, Cai J. PMID: 41543776 [PubMed - indexed for MEDLINE]
	The impact of depressive symptoms on 5-year all-cause mortality in patients with parkinson's disease treated with and without deep brain stimulation. J Neural Transm (Vienna) Marschoun S, Treven M, Brücke C, Lehrner J. PMID: 41543763 [PubMed - as supplied by publisher]
	Is Parkinson's disease getting older? Demographic and modifiable determinants of age at onset in a large Italian tertiary care cohort. J Neurol Contaldi E, Bonomi A, Calandrella D, Sacilotto G, Zini M, Del Sorbo F, Soliveri P, Zecchinelli A, Isaias IU, Pezzoli G. PMID: 41543607 [PubMed - indexed for MEDLINE]
	Correlation of Plasma Neuropeptide Y with Specific Cognitive Domains in Patients with Parkinson's Disease Cognitive Impairment. Clin Lab Zhang AR, Wu ML, Pang WJ, Ning XB, Wu YJ, Pang JF. PMID: 41543103 [PubMed - indexed for MEDLINE]
	The iTrail making test (iTMT): an evaluation of novel testing paradigms, hidden indices of measurement, and diagnostic accuracy in Parkinson's disease. J Clin Exp Neuropsychol Murphy D, Scott J, Newman C, Noad R. PMID: 41543001 [PubMed - as supplied by publisher]
	Machine Learning Prediction of Discharge Destination in Patients with Parkinson's Disease; A Nationwide Cohort Study. Res Sq Kamo H, Mehta TR, Remz M, Burke RM, Brooks A, Smiley A, Okun MS, Hess CW. PMID: 41542037 [PubMed]
	Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease. Mov Disord Clin Pract Chaudhuri KR, Bergmans B, Freire-Alvarez E, Hopes L, Kern DS, Kirsner RS, Lazzeri G, Mendes-Bastos P, Nishikawa N, Odin P, Poplawska-Domaszewicz K, Pahwa R, Ramot Y, Seppi K, Warnecke T, Wiggins R, Shah MB, Kukreja P, Fritz B, Onuk K, Isaacson SH. PMID: 41540973 [PubMed - as supplied by publisher]
	Visuospatial dysfunction indicates an increased risk of rapid dementia conversion in Parkinson's disease. Alzheimers Dement Park CW, Choi Y, Sun Y, Lee HS, Lee PH, Kim YJ, Sohn YH, Lee J, Chung SJ. PMID: 41540811 [PubMed - indexed for MEDLINE]
	Methamphetamine-Driven Neuroinflammation and Parkinson's Disease Pathology: Mechanistic Insight into Nrf2 and NFÄ¸B Signaling. Mol Neurobiol Kalia N, Kuwar OK. PMID: 41540154 [PubMed - indexed for MEDLINE]
	Dissociating dopaminergic and nondopaminergic motor loads in Parkinson's disease: clinical correlates, non-motor interactions, and quality-of-life implications. Neurol Sci Onder H, Kurt E, Bozkus R, Comoglu S. PMID: 41540142 [PubMed - indexed for MEDLINE]
	Multi-omic insight into the molecular mechanism of cuproptosis-related genes in the pathogenesis of Parkinson's disease. NPJ Parkinsons Dis Zhang T, Wang Y. PMID: 41540060 [PubMed - as supplied by publisher]

Articles 1 - 20 / 56158

Page 1 of 2808



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy